Cytogenetic analysis of obsessive-compulsive disorder (OCD): Identification of a FRAXE fragile site

Obsessive‐compulsive disorder (OCD) is a chronic psychiatric disease characterized by recurrent obsessions, compulsions, or both. The prevalence rate of OCD is 2.1% in the general population. Here we report cytogenetic analysis of 26 patients affected with OCD. In one male patient (OCD‐K33), we iden...

Full description

Saved in:
Bibliographic Details
Published in:American journal of medical genetics. Part A 2003-04, Vol.118A (1), p.25-28
Main Authors: Wang, Qing, Gu, Yanghong, Ferguson, James M., Chen, Qiuyun, Boatwright, Scott, Gardiner, James, Below, Cheryl, Espinosa, Janna, Nelson, David L., Shaffer, Lisa G.
Format: Article
Language:English
Subjects:
Chromosomes, Human, X
Female
FMR2
fragile X chromosome
Fragile X Syndrome - genetics
FRAXA
FRAXE
FRAXF
genetics
Humans
Male
mental retardation
neurologic disorder
obsessive-compulsive disorder (OCD)
Obsessive-Compulsive Disorder - genetics
Pedigree
speech impairment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Obsessive‐compulsive disorder (OCD) is a chronic psychiatric disease characterized by recurrent obsessions, compulsions, or both. The prevalence rate of OCD is 2.1% in the general population. Here we report cytogenetic analysis of 26 patients affected with OCD. In one male patient (OCD‐K33), we identified a fragile X chromosome by cytogenetic analysis with 21% of cells demonstrating a fragile site at Xq27‐q28. Polymerase chain reaction (PCR) and Southern blot analysis demonstrated that the molecular basis of the OCD‐K33 fragile X chromosome was expansion of the CCG repeat at FRAXE. The number of the expanded repeats was estimated to be more than 300 copies, qualifying it as a full FRAXE mutation. Further analysis of the family members of OCD‐K33 revealed another member with a full FRAXE mutation (630–1,200 copies of the CCG repeat), who had the clinical phenotype of speech impairment, and two other members with normal phenotypes and no FRAXE expansion. The two FRAXE expansions lead to complete methylation at the CCG repeat. The co‐segregation of the full FRAXE mutation with apparent neurologic disorders in the same family provides further support to the notion that FRAXE is a genetic neurologic condition. Our findings expand the spectrum of clinical phenotypes associated with FRAXE mutations. © 2003 Wiley‐Liss, Inc.
ISSN:1552-4825
1552-4833
DOI:10.1002/ajmg.a.20001